In the BioHarmony Drug Report Database
Peginterferon beta-1a
Plegridy (peginterferon beta-1a) is a protein pharmaceutical. Peginterferon beta-1a was first approved as Plegridy on 2014-07-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.
Trade Name
|
Plegridy |
|---|---|
Common Name
|
peginterferon beta-1a |
ChEMBL ID
|
CHEMBL2108677 |
Indication
|
multiple sclerosis |
Drug Class
|
Pegylated compounds |
Image (chem structure or protein)
